A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
Condition: Healthy Subjects Interventions: Drug: SID1903 (FDC); Drug: Dapagliflozin and Sitagliptin Sponsor: SK Chemicals Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2022 Category: Research Source Type: clinical trials
